Parameters
|
Groups
|
Baseline
|
Week 12
|
Week 24
|
---|
UAER (μg/min)
|
TSF
|
157.6 ± 72.9
|
115.9 ± 50.7
|
104.0 ± 32.4a
|
Placebo
|
158.6 ± 99.0
|
116.5 ± 69.7
|
121.8 ± 69.7
|
BUN (mmol/L)
|
TSF
|
5.1 ± 1.2
|
5.6 ± 1.4
|
5.5 ± 1.4
|
Placebo
|
5.7 ± 1.6
|
6.6 ± 1.5
|
6.0 ± 2.3
|
Scr (μmol/L)
|
TSF
|
73.5 ± 19.3
|
64.4 ± 19.7
|
67.6 ± 16.7
|
Placebo
|
60.8 ± 18.2
|
62.7 ± 19.8
|
61.9 ± 15.1
|
eGFR (ml/min/1.73 m2)
|
TSF
|
102.7 ± 39.2
|
118.3 ± 49.4
|
113.9 ± 53.5
|
Placebo
|
128.3 ± 61.0
|
124.8 ± 45.2
|
121.0 ± 44.0
|
ln plasma L-FABP (μg/ml)
|
TSF
|
1.0 ± 0.9
|
1.3 ± 0.8
|
1.2 ± 0.7
|
Placebo
|
1.4 ± 0.7
|
1.7 ± 0.6
|
1.1 ± 0.7
|
- All values expressed as mean ± SD
-
a: P < 0.05 compared with baseline of the same group (Paired t test)
- Abbreviations: BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, ln plasma L-FABP ln-transformed plasma liver-type fatty acid binding protein, Scr serum creatinine, UAER urinary albumin excretion rate